Limelight Networks Inc (LLNW)


Stock Price Forecast

July 15, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Limelight Networks Inc chart...

About the Company

Limelight Networks, Inc. a leading provider of digital content delivery, video, cloud security, and edge computing services, empowers customers to provide exceptional digital experiences. Limelight's edge services platform includes a unique combination of global private infrastructure, intelligent software, and expert support services that enable current and future workflows.

Employees

618

CEO

Robert Lento

Exchange

NASDAQ

Website

www.limelightnetworks.com

$224M

Total Revenue

618

Employees

$289M

Market Capitalization

-5.41

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LLNW News

Content Delivery Network (CDN) Market Poised for 20.8% CAGR Growth, Eyes US$ 155,461.3 Million Value by 2033

10d ago, source: Future Market Insights

The global content delivery networks (CDN) market is projected to achieve a valuation of US$ 155,461.3 Million by 2033, demonstrating a CAGR of 20.8%. This signifies a substantial surge compared to ...

Craig-Hallum Keeps Their Hold Rating on Edgio (EGIO)

10d ago, source: Business Insider

See which 3 stocks are most likely to make moves following their insider activities. Edgio (EGIO) Company Description: Limelight Networks, Inc. provides content delivery network services. It products ...

Warrant Issued for St. Cloud Man Who Failed to Appear for Verdict

10d ago, source: WJON

The last of three men involved in a south St. Cloud shooting that injured four people is a wanted man after he failed to show ...

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

13h ago, source:

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

‘Cosmos is more than ever in the same conversation as many other projects’, says Binary Builders’ product lead

10d ago, source: Crypto Briefing

Cosmos SDK is suitable for most of the current projects needs, and Cosmos could be in the limelight again, says Marko ...

Investing in the Thriving Spirulina Extract Market: Forecasted Growth to US$ 234.8 Million by 2034 | FMI Projection

2d ago, source: Future Market Insights

Spirulina Extracts Market Explore the lucrative potential of the spirulina extract market with a projected valuation of US$ ...

Cloud Content Delivery Network Market Driven by Demand for Seamless Online Experiences

9d ago, source:

Cloud Content Delivery Network Market Scope and Overview. The SNS Insider report indicates that the Cloud Content Delivery ...

Fairhaven Woman Needs Sponsors to Keep Racing in Son’s Memory

2d ago, source: wbsm

At first, Christine Peirce was racing in a 1978 Camaro for herself, but now she races for something bigger – the memory of ...

“The magic is easily achievable”: Give your guitar a Hentor Sportscaster makeover and nail Moving Pictures-era Rush tones as Alex Lifeson’s Lerxst debuts the Limelight ...

15d ago, source: MusicRadar on MSN

Nail Alex Lifeson’s Moving Pictures-era tone with the Lerxst Limelight pre-wired pickguard ...

Grand Store Launch Of Limelight Diamonds At Kankurgachi, Kolkata By Adah Sharma

8d ago, source:

Limelight Diamonds, India's largest CVD diamond jewellery brand is delighted to announce its second store in Kolkata in a ...

RJD2 Returns With New Album ‘Visions Out Of Limelight’ – Shares Textural First Single “Through It All”

10d ago, source: Glide Magazine

RJD2 has announced his new album, Visions Out Of Limelight, out June 14th via RJ’s Electrical Connections, and shares its lead single/video, “Through It ...

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

15h ago, source:

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...